Value proposition

European Mammalian CRDMO - From Discovery mgs to Clinical GMP kgs.

We're a leading European biotechnology company, providing streamlined or custom-tailored services for global clients in pharmaceutical, biotechnology industries, and academia.

We've been a privately held family business since 1999, and have grown into a leading mammalian Contract Research, Development, and Manufacturing Organization (CRDMO). The CRDMO approach allows us to cover the entire spectrum of pre-clinical and clinical services - from the initial stages of target discovery and development, to cell line development, and manufacturing of mammalian therapeutic proteins, up to 1000 L scale.

In 2023, we worked with more than 100 drug or vaccine development companies globally, producing more than 2400 different proteins. Clients trust us for custom-tailored solutions in every stage of drug substance development.

biotech, pharma, research, CDMO, CRO, antibody discovery, transmembrane proteins, GMP manufacturing, cell line development , transient expression, cell culture, process development , bispecific antibodies, diagnostics, mammalian cells, biopharmaceutical manufacturing, and protein drug substance development